Primary contact

Formerly known as Health2047 SwitchCo, Akiri is developing a vendor-agnostic solution — called Akiri Switch — that uses software-defined network (SDN) and secure routing protocol technology optimized for healthcare data. The company leverages blockchain principles to help securely transmit information in real time through a standardized system of codes. As a result, Akiri Switch's benefits extend beyond those offered by health information exchanges (HIEs); extract, transform, load (ETL) processes; and EMR systems. Among Akiri's partners are organizations such as the American Medical Association (AMA) and the global pharmaceutical company, Celgene.
Primary contact

Funding 💰

Total $10M
Select investors Health2047
Last update: November 5, 2018